Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
Washington University School of Medicine
Eastern Cooperative Oncology Group
Stanford University
Cedars-Sinai Medical Center
Istituti Clinici Scientifici Maugeri SpA
Ohio State University Comprehensive Cancer Center
Haukeland University Hospital
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Northwestern University
Tampere University Hospital
University of Virginia